Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/25/2021
Aurobindo intros generic Gleevec
Imatinib mesylate tablets have a market value of roughly $324 million for the 12 months ended January 2021, according to IQVIA. - 3/24/2021
Aetna Better Health of California taps Verne Brizendine as CEO
Verne Brizendine will be responsible for the health plan’s operations and strategy to help members achieve better health outcomes. - 3/24/2021
McKesson approved as QCDR for 2021 CMS merit-based incentive payment system
CMS approved all eight of the oncology-specific custom QCDR measures developed by The US Oncology Network and submitted as part of McKesson’s 2021 application. - 3/23/2021
Alembic issues voluntary nationwide recall of 20-mg telmisartan
The product is being recalled due to a market complaint received, stating that one bottle labeled as 30-count telmisartan tablets 20 mg incorrectly contained 30 tablets of 40-mg telmisartan tablets. - 3/23/2021
Merck gets FDA nod for new indication of Keytruda
Merck's Keytruda is now FDA approved as a treatment for esophageal cancer or gastroesophageal junction carcinoma. - 3/23/2021
Uber expands prescription delivery with ScriptDrop
Uber will become the default courier for select pharmacies using ScriptDrop, depending on location and driver availability. - 3/23/2021
FDA approves Glenmark’s generic Thorazine
Thorazine had a market value of roughly $108.6 million for the 12 months ended January 2021, according to IQVIA. - 3/23/2021
NCPA releases reports reflecting on COVID-19, advocacy efforts in 2020
With two new reports, the National Community Pharmacists Association is reflecting on its extensive efforts to help independent pharmacists amid the pandemic, as well as its advocacy efforts on behalf of independent community pharmacists. - 3/22/2021
Study finds Medicare Part D plans adding more generic drugs onto non-preferred drug tier
A study from Avalere, funded by the Association for Accessible Medicines, found that in 2021, Medicare Part D plans placed generic prescription drugs on generic tiers 45% of the time, a decrease from 64% in 2016. - 3/22/2021
Glenmark obtains FDA OK for generic Cardizem
Cardizem had a market value of approximately $56.7 million for the 12 months ended January 2021, according to IQVIA.
